Newron Pharmaceuticals (NWPHF) Short Interest Ratio & Short Volume $9.36 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Newron Pharmaceuticals Short Interest DataNewron Pharmaceuticals (NWPHF) has a short interest of 124,100 shares. This marks a -0.64% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1,241.0, indicating that it would take 1,241.0 days of the average trading volume of 600 shares to cover all short positions.Current Short Interest124,100 sharesPrevious Short Interest124,900 sharesChange Vs. Previous Month-0.64%Dollar Volume Sold Short$1.16 millionShort Interest Ratio1,241.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares17,850,000 sharesPercentage of Shares Shorted0.70%Today's Trading Volume0 sharesAverage Trading Volume600 sharesToday's Volume Vs. Average0% Short Selling Newron Pharmaceuticals? Sign up to receive the latest short interest report for Newron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNWPHF Short Interest Over TimeNWPHF Days to Cover Over TimeNWPHF Percentage of Float Shorted Over Time Ad TradingTips10 EV Stocks to Buy Right NowEV stocks are red hot. We’ve found TEN that we think will produce big wins for early investors. There’s no charge to view this report, so I urge everyone to check out the 10 stocks we’ve found as soon as possible.Click here to view all 10 stocks right away. Newron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024124,100 shares $1.16 million -0.6%N/A1241 $9.36 9/30/2024124,900 shares $1.17 million +29.8%N/A1249 $9.36 9/15/202496,200 shares $900,432.00 +0.3%N/A962 $9.36 8/31/202495,900 shares $872,690.00 +73.1%N/A0 $9.10 8/15/202455,400 shares $504,140.00 +1.3%N/A277 $9.10 7/31/202454,700 shares $656,400.00 -30.8%N/A0 $12.00 Get the Latest News and Ratings for NWPHF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Newron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/202479,000 shares $948,000.00 +381.7%N/A0 $12.00 6/30/202416,400 shares $196,800.00 +10.1%N/A82 $12.00 6/15/202414,900 shares $142,295.00 No ChangeN/A74.6 $9.55 5/31/202414,900 shares $178,800.00 -0.7%N/A0 $12.00 5/15/202415,000 shares $180,000.00 -46.8%N/A75 $12.00 4/30/202428,200 shares $240,264.00 +28,100.0%N/A282 $8.52 4/15/2024100 shares $852.00 -99.8%N/A0 $8.52 3/31/202444,600 shares $379,992.00 +50.7%N/A0 $8.52 3/15/202429,600 shares $252,192.00 +60.0%N/A0 $8.52 2/29/202418,500 shares $157,620.00 +537.9%N/A0 $8.52 2/15/20242,900 shares $24,708.00 +480.0%N/A0 $8.52 1/15/20242,700 shares $21,330.00 -89.2%N/A6.8 $7.90 12/31/202324,900 shares $129,978.00 +66.0%N/A101.9 $5.22 12/15/202315,000 shares $93,300.00 -35.3%N/A0 $6.22 11/30/202323,200 shares $144,304.00 -27.0%N/A0 $6.22 11/15/202331,800 shares $197,796.00 +27.2%N/A0 $6.22 10/31/202325,000 shares $155,500.00 +24,900.0%N/A0 $6.22 10/15/2023100 shares $622.00 -99.5%N/A0 $6.22 9/30/202318,600 shares $115,692.00 -22.5%N/A0 $6.22 9/15/202324,000 shares $149,280.00 +566.7%N/A0 $6.22 8/31/20233,600 shares $22,392.00 -63.3%N/A35 $6.22 8/15/20239,800 shares $19,796.00 -10.9%N/A0 $2.02 7/31/202311,000 shares $22,220.00 +10,900.0%N/A0 $2.02 7/15/2023100 shares $202.00 No ChangeN/A1 $2.02 6/30/2023100 shares $202.00 No ChangeN/A0 $2.02 6/15/2023100 shares $202.00 No ChangeN/A0 $2.02 5/31/2023100 shares $202.00 -97.1%N/A0 $2.02 5/15/20233,500 shares $7,070.00 +3,400.0%N/A0 $2.02 4/30/2023100 shares $202.00 -99.5%N/A0 $2.02 4/15/202319,200 shares $38,784.00 -70.4%N/A0 $2.02 3/31/202364,900 shares $131,098.00 -35.5%N/A0 $2.02 3/15/2023100,600 shares $203,212.00 +21.5%N/A0 $2.02 2/28/202382,800 shares $167,256.00 +82,700.0%N/A828 $2.02 2/15/2023100 shares $202.00 -91.7%N/A0 $2.02This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 1/31/20231,200 shares $2,424.00 +1,100.0%N/A0 $2.02 1/15/2023100 shares $202.00 No ChangeN/A1 $2.02 12/15/2022100 shares $210.00 No ChangeN/A0 $2.10 11/30/2022100 shares $210.00 No ChangeN/A0 $2.10 11/15/2022100 shares $210.00 No ChangeN/A0 $2.10 10/31/2022100 shares $210.00 No ChangeN/A0 $2.10 10/15/2022100 shares $210.00 No ChangeN/A0 $2.10 9/30/2022100 shares $210.00 No ChangeN/A0 $2.10 9/15/2022100 shares $210.00 No ChangeN/A0 $2.10 8/31/2022100 shares $210.00 No ChangeN/A0 $2.10 8/15/2022100 shares $210.00 No ChangeN/A0 $2.10 7/31/2022100 shares $210.00 No ChangeN/A0 $2.10 7/15/2022100 shares $210.00 No ChangeN/A0 $2.10 6/30/2022100 shares $210.00 No ChangeN/A0 $2.10 6/15/2022100 shares $210.00 No ChangeN/A0 $2.10 5/31/2022100 shares $210.00 No ChangeN/A0 $2.10 5/15/2022100 shares $210.00 No ChangeN/A0 $2.10 4/30/2022100 shares $210.00 No ChangeN/A0 $2.10 4/15/2022100 shares $210.00 No ChangeN/A0 $2.10 3/31/2022100 shares $210.00 No ChangeN/A0 $2.10 3/15/2022100 shares $210.00 No ChangeN/A0 $2.10 2/28/2022100 shares $210.00 No ChangeN/A0 $2.10 2/15/2022100 shares $210.00 No ChangeN/A0 $2.10 1/31/2022100 shares $210.00 No ChangeN/A0 $2.10 1/15/2022100 shares $210.00 No ChangeN/A0 $2.10 12/31/2021100 shares $210.00 No ChangeN/A0.3 $2.10 12/15/2021100 shares $280.00 No ChangeN/A0 $2.80 11/30/2021100 shares $280.00 No ChangeN/A0 $2.80 11/15/2021100 shares $280.00 No ChangeN/A0 $2.80 10/29/2021100 shares $280.00 No ChangeN/A0 $2.80 10/15/2021100 shares $280.00 No ChangeN/A0 $2.80 9/30/2021100 shares $280.00 No ChangeN/A0 $2.80 9/15/2021100 shares $280.00 No ChangeN/A0 $2.80 8/31/2021100 shares $280.00 -98.7%N/A0 $2.80 8/13/20217,700 shares $21,560.00 +7,600.0%N/A0 $2.80 7/30/2021100 shares $280.00 No ChangeN/A0 $2.80 7/15/2021100 shares $280.00 No ChangeN/A0 $2.80 6/30/2021100 shares $280.00 No ChangeN/A0 $2.80 6/15/2021100 shares $280.00 No ChangeN/A0.1 $2.80 5/28/2021100 shares $280.00 No ChangeN/A1 $2.80 5/14/2021100 shares $280.00 No ChangeN/A0 $2.80 4/30/2021100 shares $280.00 No ChangeN/A0 $2.80 4/15/2021100 shares $280.00 No ChangeN/A0 $2.80 3/31/2021100 shares $300.00 -98.1%N/A0.5 $3.00 3/15/20215,300 shares $12,935.18 +5,200.0%N/A2.8 $2.44 2/26/2021100 shares $244.06 No ChangeN/A0 $2.44 2/12/2021100 shares $244.06 -92.9%N/A0 $2.44 1/29/20211,400 shares $3,416.84 +1,300.0%N/A0 $2.44 1/15/2021100 shares $244.06 No ChangeN/A0 $2.44 12/31/2020100 shares $244.06 No ChangeN/A0.1 $2.44This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 12/15/2020100 shares $247.00 No ChangeN/A0 $2.47 11/30/2020100 shares $196.29 No ChangeN/A0 $1.96 11/15/2020100 shares $196.29 No ChangeN/A0.1 $1.96 10/30/2020100 shares $190.00 No ChangeN/A1 $1.90 10/15/2020100 shares $202.00 -93.8%N/A0.5 $2.02 9/30/20201,600 shares $4,080.00 +1,500.0%N/A0 $2.55 9/15/2020100 shares $255.00 No ChangeN/A0 $2.55 8/31/2020100 shares $255.00 -90.0%N/A1 $2.55 8/14/20201,000 shares $2,500.00 +900.0%N/A10 $2.50 7/31/2020100 shares $181.00 No ChangeN/A0 $1.81 7/15/2020100 shares $181.00 No ChangeN/A0 $1.81 6/30/2020100 shares $181.00 No ChangeN/A0.2 $1.81 6/15/2020100 shares $180.10 No ChangeN/A0.2 $1.80 5/29/2020100 shares $890.00 No ChangeN/A1 $8.90 5/15/2020100 shares $750.00 -99.3%N/A1 $7.50 4/30/202014,000 shares $105,000.00 +25.0%N/A0 $7.50 4/15/202011,200 shares $84,000.00 -69.1%N/A0 $7.50 3/31/202036,200 shares $271,500.00 +44.8%N/A0 $7.50 3/13/202025,000 shares $187,500.00 No ChangeN/A250 $7.50 2/28/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 2/14/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 1/31/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 1/15/202025,000 shares $187,500.00 -1.2%N/A250 $7.50 12/31/201925,300 shares $189,750.00 -41.4%N/A0 $7.50 NWPHF Short Interest - Frequently Asked Questions What is Newron Pharmaceuticals' current short interest? Short interest is the volume of Newron Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 124,100 shares of NWPHF short. Learn More on Newron Pharmaceuticals' current short interest. What is a good short interest ratio for Newron Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NWPHF shares currently have a short interest ratio of 1,241.0. Learn More on Newron Pharmaceuticals's short interest ratio. Is Newron Pharmaceuticals' short interest increasing or decreasing? Newron Pharmaceuticals saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 124,100 shares, a decline of 0.6% from the previous total of 124,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Newron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Newron Pharmaceuticals: ABIVAX Société Anonyme (0.41%), Ironwood Pharmaceuticals, Inc. (7.67%), Astria Therapeutics, Inc. (7.36%), Y-mAbs Therapeutics, Inc. (11.49%), Avid Bioservices, Inc. (20.68%), CureVac (5.03%), Stoke Therapeutics, Inc. (12.90%), Entrada Therapeutics, Inc. (7.64%), Tango Therapeutics, Inc. (15.42%), Acelyrin, Inc. (8.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Newron Pharmaceuticals stock? Short selling NWPHF is an investing strategy that aims to generate trading profit from Newron Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Newron Pharmaceuticals? A short squeeze for Newron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NWPHF, which in turn drives the price of the stock up even further. How often is Newron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWPHF, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies ABIVAX Société Anonyme Short Squeeze Ironwood Pharmaceuticals Short Squeeze Astria Therapeutics Short Squeeze Y-mAbs Therapeutics Short Squeeze Avid Bioservices Short Squeeze CureVac Short Squeeze Stoke Therapeutics Short Squeeze Entrada Therapeutics Short Squeeze Tango Therapeutics Short Squeeze Acelyrin Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWPHF) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Newron Pharmaceuticals S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Newron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.